Allergy Therapeutics PLC
LSE:AGY
Allergy Therapeutics PLC
LSE:AGY
Price:
2.875 GBX
Market Closed
Updated:
May 4, 2024
Allergy Therapeutics PLC
Net Income (Common)
|
Allergy Therapeutics PLC
Net Income (Common) Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Net Income (Common)
-£50.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Income (Common)
£4.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Net Income (Common)
$6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
|
Indivior PLC
LSE:INDV
|
Net Income (Common)
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Income (Common)
$190m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Income (Common)
-£27.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Allergy Therapeutics PLC's Net Income (Common)?
Net Income (Common)
-50.2m
GBP
-50.2m
GBP
Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Net Income (Common) amounts to -50.2m GBP.
What is Allergy Therapeutics PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-73%
-73%
Over the last year, the Net Income (Common) growth was -73%.
You don't have any saved screeners yet
